Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
about
Terlipressin for hepatorenal syndromeHepatorenal syndromeCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisAlbumin for end-stage liver diseaseHepatorenal syndrome and ascites--an introduction.TIPSS 10 years on.Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.Prevention of acute renal failure in the critically ill.Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.Therapy insight: Management of hepatorenal syndrome.Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.Management of refractory ascites and hepatorenal syndrome.Hepatorenal syndrome in patients with cirrhosis.Extracorporeal support for patients with hepatic failure.Review article: albumin in the treatment of liver diseases--new features of a classical treatment.Review article: albumin for circulatory support in patients with cirrhosis.Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II studyIncreased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?Review article: prognosis of hepatorenal syndrome--has it changed with current practice?Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.Review article: pharmacological treatment of hepatorenal syndrome.Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!Hepatorenal syndrome: a dreaded complication of end-stage liver disease.Review article: current management of renal dysfunction in the cirrhotic patient.Variceal bleeding: pharmacological therapy.Albumin therapy in clinical practice.Meta-analysis: terlipressin therapy for the hepatorenal syndrome.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeAcute kidney injury in cirrhosis.Pathogenesis and management of alcoholic liver cirrhosis: a review.Treatment of hepatorenal syndrome.Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.Clinical use of albumin in hepatology.Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation.
P2860
Q24243962-8D16B571-27B5-44BD-88E0-5E24414022B9Q24682192-BDD105D5-0FD2-425C-86E1-FBE28D540CE9Q26795734-3AF583D5-2F43-42D3-A51B-35305331AF93Q26999804-121BAFEF-742B-4FF4-8CB9-18B27F8213DEQ33607445-B7F42AA5-5F51-48CB-9BB1-A1ADAA87C646Q33862574-4914B1C4-62C7-4BB6-9655-8A41D0877B25Q33875124-A0DE141E-293A-4804-81E9-5A2F0B75E6B4Q33904314-F697525D-4453-49AE-8C13-1B6A56C6F17CQ34511403-9FB80212-B4BF-4BD5-A4B4-8DCBF85D2B46Q34526007-7B5A2F45-7243-469D-BA60-51D4242D7F73Q34533221-69294AB5-7399-4C6E-9CDD-1B6D07D6FB48Q34601701-042415F0-29CD-4DFF-B13A-4D971A08696BQ34619402-87857136-D485-46A3-B7E3-0FBA0965A77EQ34744285-0FEF2680-CE81-4D4E-8F1E-96A828E02708Q34976765-EBD3612D-03A0-4BD0-A116-3FB0699E27DCQ34992519-53DA8894-85F5-488F-AC3B-E4B66DA26C18Q34992534-25DD3687-ADAB-46CB-8914-BEA5EDBDB4FCQ35360714-E15F0267-F06E-4CA4-BB3D-11B3271443FDQ35362183-D57A74C0-A886-498D-A0D7-888EE979C05CQ35654104-74EADD39-5C05-4FCF-BCA7-2A7FC25467D9Q35873829-45B1C519-C5B8-45AB-8742-DB92B8D13ADEQ35873832-BAF3EB35-7E0E-4AC8-92D1-740F994C67EBQ35873836-4B75C185-3A5E-4824-98A8-1F73AA8579F1Q35873840-A0CE70C2-65E5-4A26-80DC-22E08E464AF8Q35994071-8A169D94-2EDF-4BD2-AED9-A46D83381139Q36018527-89411DEF-0350-4F56-8B35-DE99D1BEA558Q36090748-5A450C9F-B989-4454-B383-3D29EFCEC927Q36141427-AD0775B6-209F-480C-A55C-4E8E8D0BCE13Q36278377-3DF5349A-8B3A-4168-BAB7-07EA29605251Q36583826-DF575523-DFD1-4CCF-B807-DB0976BB4DDEQ36772257-2BA30D65-6C8F-4D83-92C1-0473051CD3FBQ37061659-563B37C2-7FDE-4C79-8133-594A8DE7D055Q37323711-210D950E-9EF9-4580-9577-73CD307F4E56Q37355613-8B9F7242-9296-4ABF-A8AA-DA658A628A3EQ37605883-CBE74B97-F915-4EB6-96C3-AFABC8E5649EQ37626627-F4118948-F9E3-44A5-9A21-7C27A3511773Q37634026-31FA18A7-6E4C-4C3D-9381-3F513E4D8543Q37655017-6572CFFD-11D0-446D-90FA-D918660A648BQ37674956-8AD94038-7650-4026-A1FC-41D1B0246476Q37899942-13B27462-3A8F-419F-987C-A7C327E51A6A
P2860
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@ast
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@en
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@nl
type
label
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@ast
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@en
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@nl
prefLabel
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@ast
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@en
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@nl
P2093
P356
P1433
P1476
Reversibility of hepatorenal s ...... n and plasma volume expansion.
@en
P2093
Fernández-Esparrach G
Salmerón JM
P356
10.1002/HEP.510270107
P407
P577
1998-01-01T00:00:00Z